Histogen to Report Fourth Quarter and Year-End 2020 Financial Results and Provide Business Update

Rhea-AI Summary

Histogen Inc. (NASDAQ: HSTO) is set to release its financial results for the fourth quarter and the year ended December 31, 2020, on March 11, 2021, after market close. The company is focused on developing first-in-class restorative therapeutics that leverage the body’s natural repair processes. Histogen’s technology platform utilizes cell conditioned media and extracellular matrix materials from hypoxia-induced multipotent cells, targeting various therapeutic areas, including hair growth and joint regeneration.

Positive

• Focused on developing potential first-in-class restorative therapeutics.
• Innovative technology platform utilizing cell conditioned media.
• Targets a broad range of therapeutic indications.

Negative

• None.

SAN DIEGO, March 04, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that Histogen’s financial results for the fourth quarter and year ended December 31, 2020 will be released after the close of market on Thursday, March 11, 2021.

About Histogen Inc.

Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. Histogen’s innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen’s proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including hair growth, dermal rejuvenation, joint cartilage regeneration and spinal disk repair. For more information, please visit www.histogen.com.

CONTACT:

Susan A. Knudson
Executive Vice President & CFO
Histogen Inc.
ir@histogen.com

FAQ

When will Histogen Inc. release its financial results for Q4 2020?

Histogen Inc. will release its financial results for the fourth quarter and year ended December 31, 2020, on March 11, 2021, after market close.

What is the focus of Histogen Inc.'s therapeutic development?

Histogen Inc. focuses on first-in-class restorative therapeutics that help ignite the body’s natural repair processes.

What does Histogen's technology platform utilize?

Histogen’s technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells.

What therapeutic areas does Histogen target?

Histogen targets a broad range of therapeutic areas, including hair growth, dermal rejuvenation, joint cartilage regeneration, and spinal disk repair.